Clinical Trial: Research on nano-selenium radiotherapy sensitizer and its mechanism of enhancing the efficacy and reducing the toxicity of tumors (China)

Posted On: 2026-08-21

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on nano-selenium radiotherapy sensitizer and its mechanism of enhancing the efficacy and reducing the toxicity of tumors'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130406

Registration Time: 2026/08/19

Type: Interventional study

Primary Sponsor: Sun Yat-sen University Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338960

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Research on nano-selenium radiotherapy sensitizer and its mechanism of enhancing the efficacy and reducing the toxicity of tumors (China)